Showing results (111-120 of 151) with videos related to
Sort By:
Pageof 16
Oncogene|May 1, 2018
Hypertonicity-enforced BCL-2 addiction unleashes the cytotoxic potential of death receptorsSimon Sirtl, Gertrud Knoll, Dieu Thuy Trinh, et al.Plos One|November 19, 2013
Exogenous administration of a recombinant variant of TWEAK impairs healing after myocardial infarction by aggravation of inflammationChristina Pachel, Denise Mathes, Barbara Bayer, et al.Plos One|October 14, 2017
The anti-myeloma activity of bone morphogenetic protein 2 predominantly relies on the induction of growth arrest and is apoptosis-independentCharlotte Lagler, Mohamed El-Mesery, Alexander Christian Kübler, et al.Frontiers in Immunology|November 23, 2017
Chronic Inflammation Increases the Sensitivity of Mouse Treg for TNFR2 CostimulationTobias Schmid, Lena Falter, Sabine Weber, et al.Science Signaling|January 16, 2020
Single-molecule imaging reveals the oligomeric state of functional TNFα-induced plasma membrane TNFR1 clusters in cellsChristos Karathanasis, Juliane Medler, Franziska Fricke, et al.Proceedings of the National Academy of Sciences of the United States of America|August 29, 2022
A TNF receptor 2 agonist ameliorates neuropathology and improves cognition in an Alzheimer's disease mouse modelNatalia Ortí-Casañ, Inge S Zuhorn, Petrus J W Naudé, et al.European Journal of Immunology|February 4, 2020
Tumor necrosis factor receptor family costimulation increases regulatory T-cell activation and function via NF-κBMartina Lubrano di Ricco, Emilie Ronin, Davi Collares, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 8, 2014
Activated CD8+ T cells induce expansion of Vβ5+ regulatory T cells via TNFR2 signalingJara J Joedicke, Lara Myers, Aaron B Carmody, et al.Molecular Cancer|April 19, 2014
Targeted delivery of CD40L promotes restricted activation of antigen-presenting cells and induction of cancer cell deathKim L Brunekreeft, Corinna Strohm, Marloes J Gooden, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 27, 2005
CD95 and TRAF2 promote invasiveness of pancreatic cancer cellsAnna Trauzold, Christian Röder, Bence Sipos, et al.Pageof 16